Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Bone Remodeling01:40

Bone Remodeling

38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A transcriptomic landscape analysis of human necrotizing enterocolitis: Important roles of immune infiltration.

Pediatric discovery..·2025
Same author

Advances of SIRT4 in cancer metabolism and therapy.

Pediatric discovery..·2025
Same author

Carrier frequencies, trends, and geographical distribution of hearing loss variants in China: The pooled analysis of 2,161,984 newborns.

Heliyon·2024
Same author

Aberrant LETM1 elevation dysregulates mitochondrial functions and energy metabolism and promotes lung metastasis in osteosarcoma.

Genes & diseases·2024
Same author

Origin, evolution, breeding, and omics of Apiaceae: a family of vegetables and medicinal plants.

Horticulture research·2024
Same author

The Mechanism of Ozone Oxidation of Coal and the Revelation of Coal Macromolecular Structure by Oxidation Products.

ACS omega·2024
Same journal

VX-765 alleviates motor and cognitive impairments via inhibiting PANoptosis activation in the neonatal rats after hypoxic-ischemic brain damage.

Pediatric discovery..·2025
Same journal

Assessing early left ventricular remodeling in pediatric hypertension: A study using transthoracic echocardiography combined with two-dimensional speckle tracking echocardiography in an immature rabbit model.

Pediatric discovery..·2025
Same journal

Pediatric endocardial temporary pacemaker implantation: Clinical characteristics and outcomes from a Chinese National Regional Health Center.

Pediatric discovery..·2025
Same journal

Nutritional strategies for childhood obesity treatment and prevention without counting calories-A narrative review.

Pediatric discovery..·2025
Same journal

Effect of early postoperative enteral nutrition on the short-term prognosis in neonatal gastric perforation.

Pediatric discovery..·2025
Same journal

Advances in examination methods for adolescent idiopathic scoliosis.

Pediatric discovery..·2025
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

Metabolic reprogramming in osteosarcoma.

Yulu Shi1, Xiaohan Yue1, Qing Luo1

  • 1Stem Cell Biology and Therapy Laboratory The Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health and Disorders Ministry of Education Key Laboratory of Child Development and Disorders Chongqing Key Laboratory of Pediatrics Chongqing China.

Pediatric Discovery
|July 8, 2025
PubMed
Summary
This summary is machine-generated.

Cancer cells reprogram metabolism for growth. This review details metabolic shifts in Osteosarcoma, including glycolysis, amino acid, lipid, and TCA cycle alterations, impacting tumor progression and drug resistance.

Keywords:
OXPHOSamino acidfatty acidglycolyticmetabolismosteosarcoma

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.3K

Related Experiment Videos

Last Updated: Sep 16, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.3K

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Biochemistry

Background:

  • Tumor cells exhibit metabolic reprogramming to fuel their growth and survival.
  • This reprogramming involves altered activity in key metabolic pathways like glycolysis and oxidative phosphorylation.
  • Osteosarcoma (OS) also displays distinct metabolic abnormalities linked to its malignant characteristics.

Purpose of the Study:

  • To review current research on metabolic alterations in Osteosarcoma.
  • To highlight the roles of glycolysis, amino acid metabolism, lipid synthesis, and the TCA cycle in OS.

Main Methods:

  • Literature review of studies on Osteosarcoma metabolism.
  • Analysis of metabolic pathways including glycolysis, pentose phosphate pathway, serine synthesis, glutamine metabolism, fatty acid synthesis, and oxidative phosphorylation (OXPHOS).

Main Results:

  • Metabolic reprogramming is crucial for cancer cell proliferation, migration, invasion, and drug resistance.
  • Specific metabolic pathways like glycolysis, amino acid metabolism, lipid synthesis, and the TCA cycle are significantly altered in OS.
  • These alterations contribute to the aggressive nature and treatment challenges in Osteosarcoma.

Conclusions:

  • Metabolic reprogramming is a hallmark of Osteosarcoma.
  • Understanding these metabolic shifts is vital for developing targeted therapies.
  • Further research into OS-specific metabolic vulnerabilities is warranted.